Because STAT3 activation is associated with tumor growth, reduction of T cell infiltration, and maintenance of TAM immunosuppression in the TME, we hypothesized that one possible mechanism by which CDDO-Me attenuates TAM pro-tumoral activation is through inhibiting phosphorylation of STAT3 (11, 37–39). The gene discussed is STAT3; the disease is neoplasm.